Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine

Hana Kovárová*, Marián Hajdúch, Gabriela Koínková, Petr Halada, Stanislava Krupiková, Adam Gouldsworthy, Nikolai Zhelev, Miroslav Strnad

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

53 Citations (Scopus)

Fingerprint Dive into the research topics of 'Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences